Charles River Laboratories Intl (CRL)

$184.04 -0.63 (-0.34%)
Market Cap 8.60B
Revenue (ttm) 4.05B
Net Income (ttm) 22.20M
EPS (ttm) N/A
PE Ratio 16.69
Forward PE 17.23
Profit Margin 0.55%
Debt to Equity Ratio 0.64
Volume 992,542
Avg Vol 1,049,408
Day's Range N/A - N/A
Shares Out 49.22M
Stochastic %K 74%
Beta 1.63
Analysts Strong Sell
Price Target $192.93

Company Profile

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of serv...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 222 6000
Address:
251 Ballardvale Street, Wilmington, United States
Iightning
Iightning Dec. 4 at 8:52 PM
1ightning® Premium Options Alert (Actionable) Ticker: $CRL Contract: Dec 19 $190C Entry: 3.95 Exit: 5.23 Return: +32.38% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 4 at 7:15 PM
$FTRE $CRL $ICLR $IQV $MEDP
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 4 at 7:05 PM
$CRL Current Stock Price: $184.70 Contracts to trade: $185 CRL Dec 19 2025 Call Entry: $4.60 Exit: $9.19 ROI: 100% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Iightning
Iightning Dec. 4 at 4:34 AM
1ightning® Premium Options Alert (Actionable) Ticker: $CRL Contract: Dec 19 $185C Entry: 6.15 Exit: 7.74 Return: +25.85% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Estimize
Estimize Dec. 3 at 1:09 PM
Wall St is expecting 2.34 EPS for $CRL Q4 [Reporting 02/18 BMO] http://www.estimize.com/intro/crl?chart=historical&metric_name=eps&utm_cont
0 · Reply
Iightning
Iightning Dec. 3 at 8:58 AM
1ightning® Premium Options Alert (Actionable) Ticker: $CRL Contract: Dec 19 $140C Entry: 29.55 Exit: 43.52 Return: +47.27% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 1 at 10:47 PM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $CRL **Contract:** Dec 19 $180C **Entry:** 5.05 **Exit:** 7.64 **Return:** **+51.19% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
Iightning
Iightning Nov. 26 at 1:33 AM
1ightning® Options Trade Alert (Actionable) | Buy $CRL Dec 19 $175 Call | Enter: $5.67 Exit: $10.09 | Profit: 77.87% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 11:40 AM
1ightning® Options Trade Alert (Actionable) | Buy $CRL Dec 19 $175 Call | Enter: $5.67 Exit: $10.09 | Profit: 77.87% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 12:35 AM
1ightning® Options Trade Alert (Actionable) | Buy $CRL Dec 19 $175 Call | Enter: $5.67 Exit: $10.09 | Profit: 77.87% ROI | https://1ightning.com
0 · Reply
Latest News on CRL
T. Rowe Price Transitions to Charles River's Enterprise Multi-Asset Investment Management Platform

Dec 4, 2025, 8:30 AM EST - 9 hours ago

T. Rowe Price Transitions to Charles River's Enterprise Multi-Asset Investment Management Platform

Charles River Laboratories International, Inc. (CRL) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 3, 2025, 12:43 PM EST - 1 day ago

Charles River Laboratories International, Inc. (CRL) Presents at Evercore 8th Annual Healthcare Conference Transcript

HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 1, 2025, 3:42 PM EST - 3 days ago

HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Charles River Laboratories to Present at Evercore Healthcare Conference

Dec 1, 2025, 8:00 AM EST - 3 days ago

Charles River Laboratories to Present at Evercore Healthcare Conference

Madison Small Cap Fund Q3 2025 Portfolio Activity

Nov 21, 2025, 8:35 AM EST - 13 days ago

Madison Small Cap Fund Q3 2025 Portfolio Activity

EXP HXL SAIA

Charles River Laboratories International, Inc. (CRL) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 18, 2025, 12:58 PM EST - 16 days ago

Charles River Laboratories International, Inc. (CRL) Presents at Jefferies London Healthcare Conference 2025 Transcript

SOLVE and Charles River Development Partner to Deliver Integrated Fixed Income Pricing for Investment Managers

Nov 18, 2025, 8:00 AM EST - 16 days ago

SOLVE and Charles River Development Partner to Deliver Integrated Fixed Income Pricing for Investment Managers

Charles River Laboratories to Present at Jefferies Global Healthcare Conference

Nov 17, 2025, 8:00 AM EST - 17 days ago

Charles River Laboratories to Present at Jefferies Global Healthcare Conference

Charles River Laboratories International, Inc. (CRL) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 2:21 PM EST - 4 weeks ago

Charles River Laboratories International, Inc. (CRL) Q3 2025 Earnings Call Transcript

Charles River Beat Expectations But Why Is The Stock Falling?

Nov 5, 2025, 1:38 PM EST - 4 weeks ago

Charles River Beat Expectations But Why Is The Stock Falling?

Charles River: Mixed Q3 As Strategic Review Disappoints

Nov 5, 2025, 12:33 PM EST - 4 weeks ago

Charles River: Mixed Q3 As Strategic Review Disappoints

Charles River raises annual profit forecast on stabilizing biotech demand

Nov 5, 2025, 7:34 AM EST - 4 weeks ago

Charles River raises annual profit forecast on stabilizing biotech demand

Charles River Laboratories Provides Update on Strategic Review

Nov 5, 2025, 7:01 AM EST - 4 weeks ago

Charles River Laboratories Provides Update on Strategic Review

Charles River Laboratories Announces Third-Quarter 2025 Results

Nov 5, 2025, 7:00 AM EST - 4 weeks ago

Charles River Laboratories Announces Third-Quarter 2025 Results

Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 24, 2025, 10:22 AM EDT - 5 weeks ago

Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development

Oct 22, 2025, 8:00 AM EDT - 6 weeks ago

Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development

Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities

Oct 20, 2025, 8:00 AM EDT - 6 weeks ago

Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities

Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption

Oct 15, 2025, 8:00 AM EDT - 7 weeks ago

Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption

Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call

Oct 14, 2025, 8:00 AM EDT - 7 weeks ago

Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call

Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing

Oct 8, 2025, 8:00 AM EDT - 2 months ago

Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing

Why Charles River Stock May Struggle In Its Final Phase

Oct 7, 2025, 7:22 AM EDT - 2 months ago

Why Charles River Stock May Struggle In Its Final Phase

Charles River Laboratories Announces Chief Financial Officer Transition

Sep 16, 2025, 7:05 AM EDT - 2 months ago

Charles River Laboratories Announces Chief Financial Officer Transition

Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer

Sep 11, 2025, 8:00 AM EDT - 3 months ago

Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer

Charles River Laboratories International, Inc. (CRL) Presents At Baird 2025 Global Healthcare Conference (Transcript)

Sep 10, 2025, 12:40 PM EDT - 3 months ago

Charles River Laboratories International, Inc. (CRL) Presents At Baird 2025 Global Healthcare Conference (Transcript)

Charles River Laboratories International, Inc. (CRL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 9, 2025, 1:09 PM EDT - 3 months ago

Charles River Laboratories International, Inc. (CRL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Sep 8, 2025, 8:00 AM EDT - 3 months ago

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences

Sep 3, 2025, 8:00 AM EDT - 3 months ago

Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences

Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing

Aug 26, 2025, 8:00 AM EDT - 3 months ago

Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing

Charles River (CRL) Q2 EPS Jumps 11%

Aug 6, 2025, 4:19 PM EDT - 4 months ago

Charles River (CRL) Q2 EPS Jumps 11%

Charles River Laboratories International, Inc. (CRL) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 1:30 PM EDT - 4 months ago

Charles River Laboratories International, Inc. (CRL) Q2 2025 Earnings Call Transcript

Charles River Sees Limited Impact From NIH Cuts, Tariffs, Drug Pricing

Aug 6, 2025, 12:50 PM EDT - 4 months ago

Charles River Sees Limited Impact From NIH Cuts, Tariffs, Drug Pricing

Charles River: Margin Fears Outweigh Solid Q2

Aug 6, 2025, 12:47 PM EDT - 4 months ago

Charles River: Margin Fears Outweigh Solid Q2

Charles River raises profit forecast on growing demand for drug development services

Aug 6, 2025, 7:55 AM EDT - 4 months ago

Charles River raises profit forecast on growing demand for drug development services

Charles River Laboratories Announces Second-Quarter 2025 Results

Aug 6, 2025, 7:00 AM EDT - 4 months ago

Charles River Laboratories Announces Second-Quarter 2025 Results

Charles River Joins Elly's Team to Drive Rare Disease Gene Therapy Development

Jul 22, 2025, 8:00 AM EDT - 4 months ago

Charles River Joins Elly's Team to Drive Rare Disease Gene Therapy Development

Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call

Jul 15, 2025, 8:00 AM EDT - 5 months ago

Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment

Jun 16, 2025, 8:00 AM EDT - 6 months ago

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment

Charles River Laboratories to Present at William Blair and Jefferies Conferences

Jun 2, 2025, 8:00 AM EDT - 6 months ago

Charles River Laboratories to Present at William Blair and Jefferies Conferences

Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington's Disease Research

May 28, 2025, 8:00 AM EDT - 6 months ago

Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington's Disease Research

Charles River Laboratories to Present at Bank of America Health Care Conference

May 13, 2025, 8:00 AM EDT - 7 months ago

Charles River Laboratories to Present at Bank of America Health Care Conference

Activist Elliott reaches key agreement with Charles River. Here are three ways to create value

May 10, 2025, 8:49 AM EDT - 7 months ago

Activist Elliott reaches key agreement with Charles River. Here are three ways to create value

S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments

May 7, 2025, 5:31 PM EDT - 7 months ago

S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments

Charles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call Transcript

May 7, 2025, 2:46 PM EDT - 7 months ago

Charles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call Transcript

Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs Of Demand Stabilization

May 7, 2025, 12:39 PM EDT - 7 months ago

Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs Of Demand Stabilization

Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help.

May 7, 2025, 12:17 PM EDT - 7 months ago

Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help.

Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More

May 7, 2025, 11:56 AM EDT - 7 months ago

Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More

DIS SMCI

Charles River to add new directors, review business in agreement with Elliott

May 7, 2025, 7:35 AM EDT - 7 months ago

Charles River to add new directors, review business in agreement with Elliott

Charles River Laboratories Announces First-Quarter 2025 Results

May 7, 2025, 7:01 AM EDT - 7 months ago

Charles River Laboratories Announces First-Quarter 2025 Results

Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value

May 7, 2025, 7:00 AM EDT - 7 months ago

Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value

Exclusive: Charles River agrees with Elliott to add new directors, review business

May 7, 2025, 6:08 AM EDT - 7 months ago

Exclusive: Charles River agrees with Elliott to add new directors, review business

Iightning
Iightning Dec. 4 at 8:52 PM
1ightning® Premium Options Alert (Actionable) Ticker: $CRL Contract: Dec 19 $190C Entry: 3.95 Exit: 5.23 Return: +32.38% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 4 at 7:15 PM
$FTRE $CRL $ICLR $IQV $MEDP
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 4 at 7:05 PM
$CRL Current Stock Price: $184.70 Contracts to trade: $185 CRL Dec 19 2025 Call Entry: $4.60 Exit: $9.19 ROI: 100% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Iightning
Iightning Dec. 4 at 4:34 AM
1ightning® Premium Options Alert (Actionable) Ticker: $CRL Contract: Dec 19 $185C Entry: 6.15 Exit: 7.74 Return: +25.85% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Estimize
Estimize Dec. 3 at 1:09 PM
Wall St is expecting 2.34 EPS for $CRL Q4 [Reporting 02/18 BMO] http://www.estimize.com/intro/crl?chart=historical&metric_name=eps&utm_cont
0 · Reply
Iightning
Iightning Dec. 3 at 8:58 AM
1ightning® Premium Options Alert (Actionable) Ticker: $CRL Contract: Dec 19 $140C Entry: 29.55 Exit: 43.52 Return: +47.27% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 1 at 10:47 PM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $CRL **Contract:** Dec 19 $180C **Entry:** 5.05 **Exit:** 7.64 **Return:** **+51.19% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
Iightning
Iightning Nov. 26 at 1:33 AM
1ightning® Options Trade Alert (Actionable) | Buy $CRL Dec 19 $175 Call | Enter: $5.67 Exit: $10.09 | Profit: 77.87% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 11:40 AM
1ightning® Options Trade Alert (Actionable) | Buy $CRL Dec 19 $175 Call | Enter: $5.67 Exit: $10.09 | Profit: 77.87% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 12:35 AM
1ightning® Options Trade Alert (Actionable) | Buy $CRL Dec 19 $175 Call | Enter: $5.67 Exit: $10.09 | Profit: 77.87% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 21 at 9:53 PM
1ightning® Options Trade Alert (Actionable) | Buy $CRL Dec 19 $165 Call | Enter: $7.50 Exit: $9.72 | Profit: 29.54% ROI | https://1ightning.com
0 · Reply
OpenOutcrier
OpenOutcrier Nov. 21 at 9:00 PM
RECAP 11/21 Chatter: $NVDA + Trump H200 China $CRL - CDC end Monkey tests RECAP 11/21 +Pos Comments: $FUTU + Citi $LGN + Tigress RECAP 11/21 -Neg Comments: $UPM - Barclays $IPAR - BWS Financial Live Breaking trading news www.openoutcrier.com
0 · Reply
InItToWinIt100
InItToWinIt100 Nov. 21 at 6:32 PM
$CRL
0 · Reply
OptionRunners
OptionRunners Nov. 21 at 6:30 PM
$CRL Exclusive: CDC to end all monkey research Scientists at the U.S. Centers for Disease Control and Prevention (CDC) have been told to phase out all of their monkey research, Science has learned
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 21 at 5:27 PM
$CRC $CRCL $CRDO $CRH $CRL
0 · Reply
Iightning
Iightning Nov. 21 at 12:59 AM
1ightning® Options Trade Alert (Actionable) | Buy $CRL Dec 19 $165 Call | Enter: $7.50 Exit: $9.72 | Profit: 29.54% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 10:29 PM
1ightning® Options Trade Alert (Actionable) | Buy $CRL Dec 19 $165 Call | Enter: $7.50 Exit: $9.72 | Profit: 29.54% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 19 at 6:49 AM
1ightning® Options Trade Alert (Actionable) | Buy $CRL Dec 19 $165 Call | Enter: $7.50 Exit: $9.72 | Profit: 29.54% ROI | https://1ightning.com
0 · Reply
SweepCastApp
SweepCastApp Nov. 17 at 10:03 PM
$CRL: Unusual Options Activity Alerted CALL flow observed 264x contracts at Strike price of $180 Exp on 11/21/2025 with Premium of $29K and showing NEUTRAL Sentiment
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Nov. 11 at 4:43 PM
$CRL Morgan Stanley Maintains Equal-Weight on Charles River, Raises Price Target to $185
0 · Reply
JarvisFlow
JarvisFlow Nov. 11 at 4:37 PM
Morgan Stanley updates rating for Charles River ( $CRL ) to Equal-Weight, target set at 170 → 185.
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 5:29 PM
TD Cowen updates rating for Charles River ( $CRL ) to Buy, target set at 205 → 197.
0 · Reply